Table 5 Change in EQ-5D-5L scores at week 12 from baseline (mITT population)
EQ-5D-5L domains | TII collagen (N = 30) | G + C (N = 29) | Placebo (N = 30) | p-value | |
|---|---|---|---|---|---|
TII collagen vs Placebo | G + C vs Placebo | ||||
EQ-5D—mobility | -1.00 ± 0.74 | -1.21 ± 0.73 | -0.73 ± 0.98 | 0.0255 | 0.0179 |
EQ-5D—self-care | -0.90 ± 0.84 | -1.00 ± 0.89 | -0.47 ± 0.97 | 0.0112 | 0.0340 |
EQ-5D—usual activities | -1.17 ± 0.87 | -0.93 ± 0.92 | -0.83 ± 1.02 | 0.0156 | - |
EQ-5D—pain or discomfort | -1.13 ± 0.68 | -0.97 ± 1.02 | -0.60 ± 0.72 | 0.0020 | 0.0117 |
EQ-5D—anxiety or depression | -0.90 ± 0.76 | -1.00 ± 1.07 | -0.93 ± 1.17 | - | - |
EQ-5D—VAS Score | 17.73 ± 13.78 | 18.97 ± 15.55 | 4.50 ± 13.73 | 0.0003 | 0.0009 |